Literature DB >> 9228899

Cognitive-behavioral management of drug-resistant major depressive disorder.

G A Fava1, G Savron, S Grandi, C Rafanelli.   

Abstract

BACKGROUND: The application of cognitive-behavioral treatment to drug-resistant major depression has received little research attention.
METHOD: Nineteen patients who failed to respond to at least two trials of antidepressant drugs of adequate dosages and duration were treated by cognitive-behavioral methods in an open trial.
RESULTS: Three patients dropped out of treatment. The remaining 16 patients displayed a significant (p < .001) decrease in scores on the Clinical Interview for Depression after therapy. Twelve patients were judged to be in remission at the end of the trial; only 1 of these patients was found to have relapsed at a 2-year follow-up. Antidepressant drugs were discontinued in 8 of the 12 patients who responded to cognitive-behavioral treatment.
CONCLUSION: These preliminary results suggest that a trial of cognitive-behavioral therapy by an experienced therapist should be performed before labeling an episode of major depression as "refractory" or "treatment resistant." These latter terms should apply only when a psychotherapeutic effort has been made. Until then, it seems more appropriate to define depression as "drug refractory" or "drug treatment resistant."

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9228899     DOI: 10.4088/jcp.v58n0608b

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  15 in total

Review 1.  Pharmacological treatment of depression. Consulting with Dr Oscar.

Authors:  M J Berber
Journal:  Can Fam Physician       Date:  1999-11       Impact factor: 3.275

2.  Stuck in a rut: rethinking depression and its treatment.

Authors:  Paul E Holtzheimer; Helen S Mayberg
Journal:  Trends Neurosci       Date:  2010-11-08       Impact factor: 13.837

3.  Use of depression education materials to improve treatment compliance of primary care patients.

Authors:  Francisca Azocar; Robert B Branstrom
Journal:  J Behav Health Serv Res       Date:  2006-07       Impact factor: 1.505

4.  The sequential approach to relapse prevention in unipolar depression.

Authors:  Giovanni A Fava; Chiara Ruini
Journal:  World Psychiatry       Date:  2002-02       Impact factor: 49.548

Review 5.  A risk-benefit assessment of pharmacotherapies for clinical depression in children and adolescents.

Authors:  J Renaud; D Axelson; B Birmaher
Journal:  Drug Saf       Date:  1999-01       Impact factor: 5.606

6.  Advances in the Management of Treatment-Resistant Depression.

Authors:  Paul E Holtzheimer
Journal:  Focus (Am Psychiatr Publ)       Date:  2010

Review 7.  New modalities of assessment and treatment planning in depression: the sequential approach.

Authors:  Giovanni A Fava; Elena Tomba
Journal:  CNS Drugs       Date:  2010-06       Impact factor: 5.749

Review 8.  Therapeutic options for treatment-resistant depression.

Authors:  Richard C Shelton; Olawale Osuntokun; Alexandra N Heinloth; Sara A Corya
Journal:  CNS Drugs       Date:  2010-02       Impact factor: 5.749

9.  Psychosocial functioning in patients with Treatment-Resistant Depression after group cognitive behavioral therapy.

Authors:  Miki Matsunaga; Yasumasa Okamoto; Shin-ichi Suzuki; Akiko Kinoshita; Shinpei Yoshimura; Atsuo Yoshino; Yoshihiko Kunisato; Shigeto Yamawaki
Journal:  BMC Psychiatry       Date:  2010-03-16       Impact factor: 3.630

Review 10.  What to do if an initial antidepressant fails?

Authors:  Roger S McIntyre; Aleksandra Müller; Deborah A Mancini; Eric S Silver
Journal:  Can Fam Physician       Date:  2003-04       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.